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of Medicine, Baltimore, Maryland 21205; and †Department of Psychiatry and Psychotherapy, Christian-Albrechts University, D-24105 Kiel, Germany Psychoneuroimmunology is the study of interrelationship between the immune system and the brain. Research in this area has attracted a wide range of investigators in the fields of neurology, psychiatry, immunology, and molecular biology. To some of these investigators, psychoneuroimmunology consists of studies of the effects of emotions and stress on immunological variables in otherwise normal individuals. To others, psychoneuroimmunology is the study of altered immunological parameters in patients with serious psychiatric disorders. Still other investigators focus on the neurological and psychiatric consequences of infectious and autoimmune diseases.
This special issue of BBI is focused on the presentation and discussion of immunological findings and their relevance to serious psychiatric disorders such as schizophrenia, bipolar disorder, and major depression. This focus derives from a number of recent studies that have documented a wide range of immunological abnormalities in individuals with these disorders. While many different types of abnormalities have been reported, most studies have reported alterations in cytokine expression and Tcell function. These results are potentially very exciting because they provide new mechanisms for understanding these diseases, which have puzzled generations of researchers since their characterization more than a century ago. However, the findings in studies reported to date are far from being internally consistent. Within a population of individuals with a psychiatric disease there are reports of a wide range of parameters being increased, decreased, or unchanged compared to parameters in unaffected individuals. Furthermore, the association between symptoms, clinical diagnosis, and immunological abnormality is often obscure. Finally, the mechanisms by which alternations in the immune system can lead to changes in behavior or psychiatric functioning have not been elucidated.
Three of the articles in the special issue consist of analyses of published immunological findings in individuals with major psychiatric disorders (Hinze-Selch & Pollmächer; Rothermundt, Arolt, & Bayer; Schwarz, Chiang, Müller, & Ackenheil) . All three analyses agree that there is a strong rationale for the study of the immune system in individuals with serious psychiatric disorders such as schizophrenia, bipolar disorder, and major depression. Hinze-Selch and Pollmächer supply an overview on what has already been characterized in terms of interrelationship between the cytokine, the neuroendocrine, and the central nervous systems. The reviews differ on whether or not the data already published are sufficient to support an interrelationship
